Are growing EU pharmaceutical powers a threat independence of devices sector?
This article was originally published in Clinica
Executive Summary
Just as the Global Harmonization Task Force was holding its 11th meeting in Washington, DC, to look at how to promulgate standard medical device regulations globally, EU device industry experts were convening in Copenhagen Denmark, where concerns over the overlap area with pharma revealed a threat to the very independence of the devices sector. Amanda Maxwell reports